STOCK TITAN

Carisma Therapeutics to Participate in TD Cowen's 44th Annual Health Care Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Carisma Therapeutics Inc. (CARM) will participate in the TD Cowen 44th Annual Health Care Conference. Steven Kelly, President and CEO, to speak on March 6th. Audio webcast available on the Investor Relations webpage.
Positive
  • None.
Negative
  • None.

PHILADELPHIA, Feb. 28, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that Steven Kelly, President and Chief Executive Officer, will participate in the TD Cowen 44th Annual Health Care Conference on Wednesday, March 6th at 2:50 pm ET.

An audio webcast of the event will be available on the Company's Investor Events section of the Investor Relations webpage and will be archived for a limited time following the event.

About Carisma

Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on utilizing our proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. We have created a comprehensive, differentiated proprietary cell therapy platform focused on engineered macrophages and monocytes, cells that play a crucial role in both the innate and adaptive immune response. Carisma is headquartered in Philadelphia, PA. For more information, please visit www.carismatx.com.

Investors:
Shveta Dighe
Head of Investor Relations
investors@carismatx.com

Media Contact:
Julia Stern
(763) 350-5223
jstern@realchemistry.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/carisma-therapeutics-to-participate-in-td-cowens-44th-annual-health-care-conference-302073454.html

SOURCE Carisma Therapeutics Inc.

FAQ

When will Steven Kelly participate in the TD Cowen 44th Annual Health Care Conference?

Steven Kelly will participate on Wednesday, March 6th at 2:50 pm ET.

Where can the audio webcast of the event be found?

The audio webcast will be available on the Company's Investor Events section of the Investor Relations webpage.

Will the audio webcast be accessible after the event?

Yes, the audio webcast will be archived for a limited time following the event.

Carisma Therapeutics, Inc.

NASDAQ:CARM

CARM Rankings

CARM Latest News

CARM Stock Data

18.16M
29.71M
28.54%
31.5%
1.34%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
PHILADELPHIA